Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods

by Elena Iemma | Aug 15, 2024

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis

by Elena Iemma | May 16, 2024

Does human homology reduce the potential immunogenicity of non-antibody scaffolds?

by Elena Iemma | Oct 15, 2023

Immunogenicity risk assessment of synthetic peptide drugs and their impurities

by Elena Iemma | Jul 27, 2023

Immunogenicity risk assessment of synthetic peptide drugs and their impurities – ScienceDirect

T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020

by Annie De Groot | Jun 30, 2020

2020 TCWP